Breaking News Instant updates and real-time market news.

OPHT

Ophthotech

$45.30

1.35 (3.07%)

09:32
10/06/16
10/06
09:32
10/06/16
09:32

Ophthotech price target lowered to $23 from $45 at Goldman

Goldman analyst Terence Flynn lowered Ophthotech's (OPHT) price target to $23 from $45 and reiterated his Sell rating. He revised is thesis on Ophthotech following Regeneron's (REGN) recent negative Phase II data for its co-formulation of Eylea with Rinucumab and is incrementally more cautious on success for Fovista currently in Phase III trials.

OPHT Ophthotech
$45.30

1.35 (3.07%)

06/02/16
JPMS
06/02/16
UPGRADE
Target $84
JPMS
Overweight
Ophthotech upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded Ophthotech to Overweight saying the Fovista phase 3 Lucentis combination studies reading out in Q4 have a very high probability of success. The analyst's base case assumes a four-plus letter gain in visual acuity compared to Lucentis monotherapy, resulting in 55%-60% share upside. His "homerun scenario," or five-plus letter, results in 150% share upside. He raised his price target for Ophthotech shares to $84 from $60.
09/09/16
LEER
09/09/16
NO CHANGE
LEER
Leerink updates therapeutics best ideas for 2016
In a note to investors this morning, Leerink has updated its best ideas for 2016 from the firm's five therapeutics analysts. The list includes Alexion (ALXN), Dermira (DERM), Intra-Cellular (ITCI), Sanofi (SNY), Allergan (AGN), Alnylam (ALNY), Innate Pharma (IPHYF), The Medicines Co. (MDCO), and Ophthotech (OPHT).
09/30/16
COWN
09/30/16
NO CHANGE
Target $60
COWN
Outperform
Ophthotech price target lowered to $60 from $80 at Cowen
Cowen analyst Tyler Van Buren said that Regeneron's (REGN) Phase 2 data for aflibercept co-formulated with rinucumab is negative for the class of anti-PDGFs as a whole and lowered his price target on Ophthotech (OPHT) to $60 from $80 after lowering his view of the probability of the success of its own wet AMD treatment to 50%. However, if a 3-4 letter benefit if observed when the Phase III trials read out in December, upside of $80-$120 per share from current levels is still possible, said Van Buren, who keeps an Outperform rating on Ophthotech shares.
10/04/16
JPMS
10/04/16
NO CHANGE
Target $110
JPMS
Overweight
Ophthotech price target raised to $110 from $95 at JPMorgan
JPMorgan analyst Anupam Rama raised his price target for Ophthotech to $110 from $95 citing the elimination of Regeneron (REGN) from the Wet age-related macular degeneration space following its trial failure. Ophthotech closed yesterday down $2.56 to $43.57. The stock is down 20% since last Friday amid mechanism concerns following Regeneron's phase 2 data, Rama tells investors in a research note. The analyst views the weakness in Ophthotech as a buying opportunity. There are important mechanistic differences between the company's Fovista and Regeneron's REGN2176-3, and early phase 1 data for Fovista "are comparatively more compelling," the analyst contends. He points out that the Phase 3 results with Fovista + Lucentis combination therapy are expected this quarter. The analyst keeps an Overweight rating on Ophthotech.

TODAY'S FREE FLY STORIES

LYB

LyondellBasell

$80.17

0.16 (0.20%)

06:35
06/26/17
06/26
06:35
06/26/17
06:35
Initiation
LyondellBasell initiated  »

LyondellBasell initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$122.63

1.55 (1.28%)

, DDAIF

Daimler AG

$72.99

0.17 (0.23%)

06:34
06/26/17
06/26
06:34
06/26/17
06:34
Hot Stocks
Wabco signs long-term supply agreement with Daimler Trucks »

Holdings (WBC) announced…

WBC

Wabco

$122.63

1.55 (1.28%)

DDAIF

Daimler AG

$72.99

0.17 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

MTNB

Matinas BioPharma

$2.77

0.25 (9.92%)

06:33
06/26/17
06/26
06:33
06/26/17
06:33
Conference/Events
Matinas BioPharma to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

EPZM

Epizyme

$14.70

1.05 (7.69%)

, RHHBY

Roche

$32.76

0.46 (1.42%)

06:33
06/26/17
06/26
06:33
06/26/17
06:33
Hot Stocks
Epizyme expands clinical collaboration with Genentech »

Epizyme (EPZM) announced…

EPZM

Epizyme

$14.70

1.05 (7.69%)

RHHBY

Roche

$32.76

0.46 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

  • 30

    Jul

P

Pandora

$8.28

0.48 (6.15%)

, SIRI

SiriusXM

$5.35

0.11 (2.10%)

06:33
06/26/17
06/26
06:33
06/26/17
06:33
Upgrade
Pandora, SiriusXM rating change  »

Pandora upgraded to…

P

Pandora

$8.28

0.48 (6.15%)

SIRI

SiriusXM

$5.35

0.11 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

SVU

Supervalu

$2.94

-0.04 (-1.34%)

06:31
06/26/17
06/26
06:31
06/26/17
06:31
Hot Stocks
Supervalu announces resignation of CFO Bruce Besanko »

Supervalu announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBS

RBS

$6.27

-0.03 (-0.48%)

06:30
06/26/17
06/26
06:30
06/26/17
06:30
Periodicals
RBS to cut 443 jobs in UK, move many of them to India, Reuters says »

Royal Bank of Scotland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

, GM

General Motors

$34.20

0.01 (0.03%)

06:27
06/26/17
06/26
06:27
06/26/17
06:27
Periodicals
Goldman's global head of equity capital markets to retire, Bloomberg reports »

Goldman Sachs' (GS)…

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

GM

General Motors

$34.20

0.01 (0.03%)

SQ

Square

$24.17

-0.11 (-0.45%)

AIG

AIG

$63.02

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 18

    Jul

  • 25

    Jul

  • 03

    Aug

  • 17

    Oct

ALNY

Alnylam

$85.21

1.25 (1.49%)

06:26
06/26/17
06/26
06:26
06/26/17
06:26
Conference/Events
Alnylam to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 06

    Jul

GOOG

Alphabet

$965.59

8.5 (0.89%)

, GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

06:25
06/26/17
06/26
06:25
06/26/17
06:25
Periodicals
Nest's head of industrial design is leaving to join LVMH, Recode reports »

Rocky Jacob, head of…

GOOG

Alphabet

$965.59

8.5 (0.89%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

LVMUY

LVMH

$51.86

0.24 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

VC

Visteon

$95.91

1.05 (1.11%)

06:23
06/26/17
06/26
06:23
06/26/17
06:23
Upgrade
Visteon rating change  »

Visteon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$71.21

0.95 (1.35%)

06:22
06/26/17
06/26
06:22
06/26/17
06:22
Periodicals
Microsoft Windows 10 source code leaked, The Register reports »

Microsoft suffered a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 20

    Jul

ENG

ENGlobal

$1.19

0.1 (9.17%)

06:21
06/26/17
06/26
06:21
06/26/17
06:21
Hot Stocks
ENGlobal announces strategic alliance with Coggins International »

ENGlobal Government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$32.76

0.46 (1.42%)

06:18
06/26/17
06/26
06:18
06/26/17
06:18
Hot Stocks
Genentech: Emicizumab showed reduction in bleeds across two pivotal studies »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

  • 30

    Jul

GM

General Motors

$34.20

0.01 (0.03%)

06:17
06/26/17
06/26
06:17
06/26/17
06:17
Periodicals
General Motors settles hundreds of ignition switch lawsuits, Reuters reports »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ILMN

Illumina

$185.28

2.29 (1.25%)

06:16
06/26/17
06/26
06:16
06/26/17
06:16
Hot Stocks
Genomics England adopts Illumina's BaseSpace variant interpreter for cancer »

Illumina and Genomics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKPYY

Takeda Pharmaceutical Co. Ltd.

$25.88

-0.04 (-0.15%)

06:15
06/26/17
06/26
06:15
06/26/17
06:15
Hot Stocks
Taked, Biological E. Limited to develop low-cost combination vaccines »

Takeda Pharmaceutical and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$55.54

-0.69 (-1.23%)

, VLKAY

Volkswagen

$30.63

-0.25 (-0.81%)

06:14
06/26/17
06/26
06:14
06/26/17
06:14
Periodicals
Harley-Davidson 'seriously considering bid' for Volkswagen's Ducati, WSJ says »

Harley-Davidson (HOG) is…

HOG

Harley-Davidson

$55.54

-0.69 (-1.23%)

VLKAY

Volkswagen

$30.63

-0.25 (-0.81%)

AUDVF

Audi AG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Oct

MMSI

Merit Medical

$37.80

0.7 (1.89%)

06:13
06/26/17
06/26
06:13
06/26/17
06:13
Recommendations
Merit Medical analyst commentary  »

Piper continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

SSNLF

Samsung

, QCOM

Qualcomm

$56.91

0.44 (0.78%)

06:10
06/26/17
06/26
06:10
06/26/17
06:10
Periodicals
Samsung to launch Galaxy Note8 in late September, VentureBeat says »

Samsung (SSNLF) is…

SSNLF

Samsung

QCOM

Qualcomm

$56.91

0.44 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ALNY

Alnylam

$85.21

1.25 (1.49%)

06:10
06/26/17
06/26
06:10
06/26/17
06:10
Hot Stocks
Alnylam: Givosian demonstrated decreased annual attack rate in study »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

CS

Credit Suisse

$13.74

-0.07 (-0.51%)

06:09
06/26/17
06/26
06:09
06/26/17
06:09
Initiation
Credit Suisse initiated  »

Credit Suisse resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

IBM

IBM

$154.11

-0.29 (-0.19%)

06:09
06/26/17
06/26
06:09
06/26/17
06:09
Hot Stocks
IBM, AEON to build blockchain-based financial platform for Asian market »

AEON Financial Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UBS

UBS

$16.06

-0.08 (-0.50%)

06:08
06/26/17
06/26
06:08
06/26/17
06:08
Upgrade
UBS rating change  »

UBS upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MTNB

Matinas BioPharma

$2.77

0.25 (9.92%)

06:07
06/26/17
06/26
06:07
06/26/17
06:07
Hot Stocks
Matinas: Clinical, mycological responses for MAT2203 didn't meet expectations »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.